April 24, 2024 COA Program Concludes Successful Annual Meeting On April 17 and 18, Critical Path Institute’s Clinical Outcome Assessment (COA) Program hosted its Annual Meeting in Rockville,
September 26, 2024-September 27, 2024 Complex In Vitro Model: Qualification Framework Public Workshop Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) is delighted to announce the second...
September 9, 2024-September 12, 2024 Save the Date for C-Path’s Premier Global Impact Conference We are thrilled to invite you to the inaugural Critical Path Institute Global Impact Conference taking place this September...
C-Path Forms Data Collaboration with International Niemann-Pick Disease Registry (INPDR) to Propel Niemann-Pick Disease Research Forward TUCSON, Ariz. April 17, 2024 — Critical Path Institute (C-Path), a leader in advancing rare disease research, today announced a
C-Path Appoints Dr. Amanda Klein as Executive Director for CPLD and CPA-1 Consortia TUCSON, Ariz., April 17, 2024 — Critical Path Institute (C-Path) today announced the appointment of Amanda Klein, Pharm.D., as E
Critical Path Institute Announces New Board Members Bonnie A. Allin and Louis Breton Critical Path Institute (C-Path) today announced the appointments of Bonnie A. Allin and Louis Breton to its Board of Directors.
June 16, 2024-June 20, 2024 Join C-Path at DIA Global 2024 C-Path CEO Klaus Romero will be a panelist in two sessions at the upcoming...
June 3, 2024-June 6, 2024 Connect with C-Path at BIO 2024: Join us on the path forward in drug development C-Path CEO Klaus Romero will be a panelist in two sessions at the upcoming BIO 2024 Conference. In two featured sessions...
March 28, 2024 C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of...
March 26, 2024 C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiency Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency...